Contact VPA to learn more about any of the case studies below highlighting results of our approach. For more case studies please visit our Downloads area, where you will find complete brochures for each of our services that include a number of other case studies in addition to the ones found here.
VPA's client had a need to re-engage staff following a major re-organisation of a global pharmaceutical company into therapeutic business units.
A mid-sized pharmaceutical company was driving to reduce lead times from discovery to launch. The requirement was to understand where the bottlenecks and slow moving processes were and what current improvements could be made.
A not for profit group was looking to understand how they should make project selection decisions for projects entering into the clinical phase, and how the priority of these incoming projects could be seen against those already in the portfolio.
A mid-sized pharmaceutical company was in the middle of a de-centralised regulatory procedure when it suddenly needed additional expertise to complete the on-going procedure. There was a need to respond to questions, finalise the labelling and manage an unexpected complication due to a member state having raised national health concerns at the end of the procedure.
VPA's client had developed a new manufacturing process for a biotech drug substance, which improved the yield, reduced the cost of goods and removed the raw materials of animal origin. However, a lengthy regulatory approval process needed to be avoided.
A new therapeutic about to enter the clinic with a range of possible different indications and disease populations needed to determine the best development path and target product profile, as well as explore the risk/reward balance between the various development options and pricing implications.
A pharmaceutical company were looking to move to disposable systems and change their primary packaging.
A non-European medical device company had developed a medical device for helping patients with osteoarthritis of the knee. While it was being used in a number of private hospitals in the UK, the company hoped to expand its usage into the NHS and so needed evidence to assist in negotiations.
Managing Partner: Claude Houet
Telephone: +49 761 600 69 355 Email: firstname.lastname@example.org